A Comprehensive Review of Organ-on-Chip/Body-on-Chip Systems: Engineering, Applications, and Potential Impact on Drug Development and Administration
DOI:
https://doi.org/10.61173/evbyvr41Keywords:
Organ-on-chip, Body-on-chip, Drug screening, Personalized Medicine, 3D BioprintingAbstract
The current drug development process faces significant challenges of a high failure rate that results in substantial time and financial waste. This is primarily attributed to the lack of pre-clinical models capable of generating physiologically relevant data essential for accurate predictions during decision-making for advancing to costly clinical stages. Fortunately, advancements in cell culture technology and material fabrication techniques have given rise to an interdisciplinary innovation known as organ-on-chip/body-on-chip (OoC/BoC), offering unparalleled physiological relevance. This review aims to provide a comprehensive overview of the materials and techniques involved in engineering OoC/BoC systems, covering the sourcing of cells from diverse origins, tissue model creation, material processing for culturing these models and coupling single OoCs into complex BoC systems. Furthermore, the potential applications of OoCs/BoCs in drug discovery processes and personalized medicine are explored. Lastly, we discuss the significant potential of this technology to revolutionize the entire drug development pipeline and the way of drug administration, as well as address the key regulatory obstacles impeding the large-scale application of the technology. In summary, this review underlines the pivotal role of OoC/BoC technology in addressing current limitations in drug development, offering promising avenues for improving efficiency, reducing costs, and advancing personalized medicine.
References
[1] Berdigaliyev N, Aljofan M. An overview of drug discovery and development. Future Med Chem. 2020;12(10):939-947. doi:10.4155/fmc-2019-0307
[2] Why 90% of clinical drug development fails and how to improve it? - ScienceDirect. Accessed March 29, 2024. https:// www.sciencedirect.com/science/article/pii/S2211383522000521
[3] George B. Regulation of Combination Products—Evolving Landscape. In: Reis RL, ed. Encyclopedia of Tissue Engineering and Regenerative Medicine. Academic Press; 2019:207-213. doi:10.1016/B978-0-12-801238-3.65582-4
[4] Ma C, Peng Y, Li H, Chen W. Organ-on-a-Chip: A New Paradigm for Drug Development Author links open overlay panel. Trends Pharmacol Sci. 2021;42(2):119-133. doi:10.1016/ j.tips.2020.11.009
[5] Negus SS, Banks ML. Pharmacokinetic-Pharmacodynamic (PKPD) Analysis with Drug Discrimination. Curr Top Behav Neurosci. 2018;39:245-259. doi:10.1007/7854_2016_36
[6] The Role of Body-on-a-Chip Devices in Drug and Toxicity Studies | Annual Reviews. Accessed March 29, 2024. https:// www.annualreviews.org/content/journals/10.1146/annurevbioeng-071910-124629#article-denial
[7] Day CP, Merlino G, Van Dyke T. Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges. Cell. 2015;163(1):39-53. doi:10.1016/j.cell.2015.08.068
[8] Robinson NB, Krieger K, Khan FM, et al. The current state of animal models in research: A review. Int J Surg. 2019;72:9-13. doi:10.1016/j.ijsu.2019.10.015
[9] AKHTAR A. The Flaws and Human Harms of Animal Experimentation. Camb Q Healthc Ethics. 2015;24(4):407-419. doi:10.1017/S0963180115000079
[10] Vinci M, Gowan S, Boxall F, et al. Advances in establishment and analysis of three-dimensional tumor spheroidbased functional assays for target validation and drug evaluation. BMC Biol. 2012;10(1):29. doi:10.1186/1741-7007-10-29
[11] van Duinen V, Trietsch SJ, Joore J, Vulto P, Hankemeier T. Microfluidic 3D cell culture: from tools to tissue models. Curr Opin Biotechnol. 2015;35:118-126. doi:10.1016/ j.copbio.2015.05.002
[12] Yu F, Hunziker W, Choudhury D. Engineering Microfluidic Organoid-on-a-Chip Platforms. Micromachines. 2019;10(3):165. doi:10.3390/mi10030165
[13] Kimura H, Sakai Y, Fujii T. Organ/body-on-a-chip based on microfluidic technology for drug discovery. Drug Metab Pharmacokinet. 2018;33(1):43-48. doi:10.1016/ j.dmpk.2017.11.003
[14] A micro cell culture analog (µCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs - Lab on a Chip (RSC Publishing). Accessed March 29, 2024. https://pubs.rsc.org/en/ content/articlelanding/2009/LC/b901377f
[15] Kane BJ, Zinner MJ, Yarmush ML, Toner M. Liver- Specific Functional Studies in a Microfluidic Array of Primary Mammalian Hepatocytes. Anal Chem. 2006;78(13):4291-4298. doi:10.1021/ac051856v
[16] Huh D, Fujioka H, Tung YC, et al. Acoustically detectable cellular-level lung injury induced by fluid mechanical stresses in microfluidic airway systems. Proc Natl Acad Sci. 2007;104(48):18886-18891. doi:10.1073/pnas.0610868104
[17] Kim HJ, Huh D, Hamilton G, Ingber DE. Human gut-ona-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip. 2012;12(12):2165-
[2174] doi:10.1039/C2LC40074J
[18] Baudoin R, Griscom L, Monge M, Legallais C, Leclerc E. Development of a Renal Microchip for In Vitro Distal Tubule Models. Biotechnol Prog. 2007;23(5):1245-1253. doi:10.1021/ Dean&Francis bp0603513
[19] Ataç B, Wagner I, Horland R, et al. Skin and hair on-achip: in vitro skin models versus ex vivo tissue maintenance with dynamic perfusion. Lab Chip. 2013;13(18):3555-3561. doi:10.1039/C3LC50227A
[20] Zhang Y, Gazit Z, Pelled G, Gazit D, Vunjak-Novakovic G. Patterning osteogenesis by inducible gene expression in microfluidic culture systems. Integr Biol. 2011;3(1):39-47. doi:10.1039/c0ib00053a
[21] Loskill P, Sezhian T, Tharp KM, et al. WAT-on-a-chip: a physiologically relevant microfluidic system incorporating white adipose tissue. Lab Chip. 2017;17(9):1645-1654. doi:10.1039/ C6LC01590E
[22] Agrawal G, Aung A, Varghese S. Skeletal muscle-on-a-chip: an in vitro model to evaluate tissue formation and injury. Lab Chip. 2017;17(20):3447-3461. doi:10.1039/C7LC00512A
[23] Agarwal A, Goss JA, Cho A, McCain ML, Parker KK. Microfluidic heart on a chip for higher throughput pharmacological studies. Lab Chip. 2013;13(18):3599-3608. doi:10.1039/C3LC50350J
[24] Booth R, Kim H. Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). Lab Chip. 2012;12(10):1784-1792. doi:10.1039/C2LC40094D
[25] Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function | PNAS. Accessed January 7, 2023. https://www.pnas.org/doi/full/10.1073/ pnas.1210182109
[26] Microphysiological heart-liver body-on-a-chip system with skin mimic for evaluating topical drug delivery - PMC. Accessed March 29, 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC7123528/
[27] Wang YI, Carmona C, Hickman JJ, Shuler ML. Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges. Adv Healthc Mater. 2018;7(2):1701000. doi:10.1002/adhm.201701000
[28] Common tools for pituitary adenomas research: cell lines and primary cells - PubMed. Accessed March 29, 2024. https:// pubmed.ncbi.nlm.nih.gov/31728905/
[29] Luni C, Serena E, Elvassore N. Human-on-chip for therapy development and fundamental science. Curr Opin Biotechnol. 2014;25:45-50. doi:10.1016/j.copbio.2013.08.015
[30] Maqsood MI, Matin MM, Bahrami AR, Ghasroldasht MM. Immortality of cell lines: challenges and advantages of establishment. Cell Biol Int. 2013;37(10):1038-1045. doi:10.1002/cbin.10137
[31] Takahashi K, Tanabe K, Ohnuki M, et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell. 2007;131(5):861-872. doi:10.1016/ j.cell.2007.11.019
[32] de Mello CPP, Rumsey J, Slaughter V, Hickman JJ. A humanon-a-chip approach to tackling rare diseases. Drug Discov Today. 2019;24(11):2139-2151. doi:10.1016/j.drudis.2019.08.001
[33] Induced Pluripotent Stem Cells for Traumatic Spinal Cord Injury - PMC. Accessed March 29, 2024. https://www.ncbi.nlm. nih.gov/pmc/articles/PMC5243807/
[34] Wnorowski A, Yang H, Wu JC. Progress, obstacles, and limitations in the use of stem cells in organ-on-a-chip models. Adv Drug Deliv Rev. 2019;140:3-11. doi:10.1016/ j.addr.2018.06.001
[35] Chan C, Berthiaume F, Nath BD, Tilles AW, Toner M, Yarmush ML. Hepatic tissue engineering for adjunct and temporary liver support: Critical technologies. Liver Transpl. 2004;10(11):1331-1342. doi:10.1002/lt.20229
[36] Reconstituting tissue patterning | Science. Accessed March 29, 2024. https://www.science.org/doi/10.1126/science.abe4217
[37] Feaugas T, Sauvonnet N. Organ-on-chip to investigate hostpathogens interactions. Cell Microbiol. 2021;23(7):e13336. doi:10.1111/cmi.13336
[38] McGuigan AP, Javaherian S. Tissue Patterning: Translating Design Principles from In Vivo to In Vitro. Annu Rev Biomed Eng. 2016;18(Volume 18, 2016):1-24. doi:10.1146/annurevbioeng-083115-032943
[39] 3D bioprinting in cardiac tissue engineering - PubMed. Accessed March 29, 2024. https://pubmed.ncbi.nlm.nih. gov/34335973/
[40] Horn TJ, Harrysson OLA. Overview of Current Additive Manufacturing Technologies and Selected Applications. Sci Prog. 2012;95(3):255-282. doi:10.3184/00368501 2X13420984463047
[41] Abbasov IB. Three-Dimensional Bioprinting of Organs: Modern Trends. Crit Rev Biomed Eng. 2022;50(3). doi:10.1615/ CritRevBiomedEng.2022043734
[42] Lee HJ, Kim YB, Ahn SH, et al. A New Approach for Fabricating Collagen/ECM-Based Bioinks Using Preosteoblasts and Human Adipose Stem Cells. Adv Healthc Mater. 2015;4(9):1359-1368. doi:10.1002/adhm.201500193
[43] Jain S, Fuoco T, Yassin MA, Mustafa K, Finne-Wistrand A. Printability and Critical Insight into Polymer Properties during Direct-Extrusion Based 3D Printing of Medical Grade Polylactide and Copolyesters. Biomacromolecules. 2020;21(2):388-396. doi:10.1021/acs.biomac.9b01112
[44] Weinhart M, Hocke A, Hippenstiel S, Kurreck J, Hedtrich S. 3D organ models—Revolution in pharmacological research? Pharmacol Res. 2019;139:446-451. doi:10.1016/ j.phrs.2018.11.002
[45] Derakhshanfar S, Mbeleck R, Xu K, Zhang X, Zhong W, Xing M. 3D bioprinting for biomedical devices and tissue engineering: A review of recent trends and advances. Bioact Mater. 2018;3(2):144-156. doi:10.1016/j.bioactmat.2017.11.008
[46] Microfluidic cell chips for high-throughput drug screening - PubMed. Accessed March 29, 2024. https://pubmed.ncbi.nlm. nih.gov/27071838/
[47] A pumpless multi-organ-on-a-chip (MOC) combined with a pharmacokinetic-pharmacodynamic (PK-PD) model - PubMed. Dean&Francis Accessed March 29, 2024. https://pubmed.ncbi.nlm.nih. gov/27570096/
[48] Tien J, Dance YW. Microfluidic Biomaterials. Adv Healthc Mater. 2021;10(4):2001028. doi:10.1002/adhm.202001028
[49] 3D Bioprinting and its application to organ-ona-chip - ScienceDirect. Accessed March 29, 2024. https://www.sciencedirect.com/science/article/abs/pii/ S0167931718304027?casa_token=LhPZwXwgJ_AAAAAA:- 4Jm2pwo4RVRKBZE5j9y-gfyJMU5ndLGdA5z8TRFvKHLt98 AwJwQkUNyQZcYBr7ASkVCaHQjehU
[50] Kuepfer L, Niederalt C, Wendl T, et al. Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model. CPT Pharmacomet Syst Pharmacol. 2016;5(10):516-531. doi:10.1002/psp4.12134
[51] Sung JH, Koo J, Shuler ML. Mimicking the Human Physiology with Microphysiological Systems (MPS). BioChip J. 2019;13(2):115-126. doi:10.1007/s13206-019-3201-z
[52] Wikswo JP, Block III FE, Cliffel DE, et al. Engineering Challenges for Instrumenting and Controlling Integrated Organon-Chip Systems. IEEE Trans Biomed Eng. 2013;60(3):682-690. doi:10.1109/TBME.2013.2244891
[53] Prothero JW. Organ scaling in mammals: The liver. Comp Biochem Physiol A Physiol. 1982;71(4):567-577. doi:10.1016/0300-9629(82)90205-5
[54] To scale or not to scale: the principles of dose extrapolation - Sharma - 2009 - British Journal of Pharmacology - Wiley Online Library. Accessed March 29, 2024. https://bpspubs.onlinelibrary. wiley.com/doi/full/10.1111/j.1476-5381.2009.00267.x
[55] Physiologically Based Pharmacokinetic Modelling for First- In-Human Predictions: An Updated Model Building Strategy Illustrated with Challenging Industry Case Studies | Clinical Pharmacokinetics. Accessed March 29, 2024. https://link. springer.com/article/10.1007/s40262-019-00741-9
[56] Messelmani T, Morisseau L, Sakai Y, et al. Liver organ-onchip models for toxicity studies and risk assessment. Lab Chip. 2022;22(13):2423-2450. doi:10.1039/d2lc00307d
[57] Mechanism-Based Pharmacokinetic-Pharmacodynamic Modeling: Biophase Distribution, Receptor Theory, and Dynamical Systems Analysis | Annual Reviews. Accessed March 29, 2024. https://www.annualreviews.org/content/ journals/10.1146/annurev.pharmtox.47.120505.105154
[58] Vernetti L, Gough A, Baetz N, et al. Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle. Sci Rep. 2017;7(1):42296. doi:10.1038/srep42296
[59] Shadpour H, Hupert ML, Patterson D, et al. Multichannel Microchip Electrophoresis Device Fabricated in Polycarbonate with an Integrated Contact Conductivity Sensor Array. Anal Chem. 2007;79(3):870-878. doi:10.1021/ac0612168
[60] Metz S, Holzer R, Renaud P. Polyimide-based microfluidic devices. Lab Chip. 2001;1(1):29-34. doi:10.1039/B103896F
[61] Pugmire DL, Waddell EA, Haasch R, Tarlov MJ, Locascio LE. Surface Characterization of Laser-Ablated Polymers Used for Microfluidics. Anal Chem. 2002;74(4):871-878. doi:10.1021/ ac011026r
[62] Steigert J, Haeberle S, Brenner T, et al. Rapid prototyping of microfluidic chips in COC. J Micromechanics Microengineering. 2007;17(2):333. doi:10.1088/0960-1317/17/2/020
[63] Torino S, Corrado B, Iodice M, Coppola G. PDMS-Based Microfluidic Devices for Cell Culture. Inventions. 2018;3(3):65. doi:10.3390/inventions3030065
[64] Joseph X, Akhil V, Arathi A, Mohanan P. Comprehensive Development in Organ-On-A-Chip Technology. J Pharm Sci. 2022;111(1):18-31. doi:10.1016/j.xphs.2021.07.014
[65] A Three-Dimensional Arrayed Microfluidic Blood-Brain Barrier Model With Integrated Electrical Sensor Array - PubMed. Accessed March 29, 2024. https://pubmed.ncbi.nlm. nih.gov/29346110/
[66] Li YC, Lin MW, Yen MH, et al. Programmable Laser- Assisted Surface Microfabrication on a Poly(Vinyl Alcohol)- Coated Glass Chip with Self-Changing Cell Adhesivity for Heterotypic Cell Patterning. ACS Appl Mater Interfaces. 2015;7(40):22322-22332. doi:10.1021/acsami.5b05978
[67] Mata A, Fleischman AJ, Roy S. Characterization of Polydimethylsiloxane (PDMS) Properties for Biomedical Micro/Nanosystems. Biomed Microdevices. 2005;7(4):281-293. doi:10.1007/s10544-005-6070-2
[68] Shakeri A, Khan S, Didar TF. Conventional and emerging strategies for the fabrication and functionalization of PDMS- based microfluidic devices. Lab Chip. 2021;21(16):3053-3075. doi:10.1039/D1LC00288K
[69] Jang K, Sato K, Tanaka Y, et al. An efficient surface modification using 2-methacryloyloxyethyl phosphorylcholine to control cell attachment via photochemical reaction in a microchannel. Lab Chip. 2010;10(15):1937-1945. doi:10.1039/ C002239J
[70] Eluru G, Adhikari JV, Chanda P, Gorthi SS. Hand-Powered Elastomeric Pump for Microfluidic Point-of-Care Diagnostics. Micromachines. 2020;11(1):67. doi:10.3390/mi11010067
[71] Chiu SH, Liu CH. An air-bubble-actuated micropump for on-chip blood transportation. Lab Chip. 2009;9(11):1524-1533. doi:10.1039/B900139E
[72] Robertson JM, Rodriguez RX, Holmes LR, Mather PT, Wetzel ED. Thermally driven microfluidic pumping via reversible shape memory polymers. Smart Mater Struct. 2016;25(8):085043. doi:10.1088/0964-1726/25/8/085043
[73] Pečar B, Križaj D, Vrtačnik D, Resnik D, Dolžan T, Možek M. Piezoelectric peristaltic micropump with a single actuator. J Micromechanics Microengineering. 2014;24(10):105010. doi:10.1088/0960-1317/24/10/105010
[74] Darabi J, Ohadi MM, DeVoe D. An electrohydrodynamic polarization micropump for electronic cooling. J Microelectromechanical Syst. 2001;10(1):98-106. doi:10.1109/84.911097 Dean&Francis
[75] Jang J, Lee SS. Theoretical and experimental study of MHD (magnetohydrodynamic) micropump. Sens Actuators Phys. 2000;80(1):84-89. doi:10.1016/S0924-4247(99)00302-7
[76] Xie J, Miao Y, Shih J, et al. An Electrochemical Pumping System for On-Chip Gradient Generation. Anal Chem. 2004;76(13):3756-3763. doi:10.1021/ac035188u
[77] Novel surface acoustic wave (SAW)-driven closed PDMS flow chamber | Microfluidics and Nanofluidics. Accessed March 29, 2024. https://link.springer.com/article/10.1007/s10404-011- 0867-5
[78] Pump-Free Microfluidic Device for the Electrochemical Detection of α1-Acid Glycoprotein - PubMed. Accessed March 29, 2024. https://pubmed.ncbi.nlm.nih.gov/34350757/
[79] Pump-Free Microfluidic Rapid Mixer Combined with a Paper-Based Channel - PubMed. Accessed March 29, 2024. https://pubmed.ncbi.nlm.nih.gov/32583663/
[80] Zhang B, Korolj A, Lai BFL, Radisic M. Advances in organon-a-chip engineering. Nat Rev Mater. 2018;3(8):257-278. doi:10.1038/s41578-018-0034-7
[81] Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development - PubMed. Accessed March 29,
[2024] https://pubmed.ncbi.nlm.nih.gov/29499151/
[82] Ingber DE. Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat Rev Genet. 2022;23(8):467-491. doi:10.1038/s41576-022-00466-9
[83] Reconstituting organ-level lung functions on a chip - PubMed. Accessed March 29, 2024. https://pubmed.ncbi.nlm. nih.gov/20576885/
[84] Modeling the Human Body on Microfluidic Chips - PubMed. Accessed March 29, 2024. https://pubmed.ncbi.nlm.nih. gov/33581889/
[85] Jalili-Firoozinezhad S, Miranda CC, Cabral JMS. Modeling the Human Body on Microfluidic Chips. Trends Biotechnol. 2021;39(8):838-852. doi:10.1016/j.tibtech.2021.01.004
[86] Moon H, Ahn H, Kodell RL, Baek S, Lin CJ, Chen JJ. Ensemble methods for classification of patients for personalized medicine with high-dimensional data. Artif Intell Med. 2007;41(3):197-207. doi:10.1016/j.artmed.2007.07.003
[87] Harvey A, Brand A, Holgate ST, et al. The future of technologies for personalised medicine. New Biotechnol. 2012;29(6):625-633. doi:10.1016/j.nbt.2012.03.009
[88] Shyr ZA, Cheng YS, Lo DC, Zheng W. Drug combination therapy for emerging viral diseases. Drug Discov Today. 2021;26(10):2367-2376. doi:10.1016/j.drudis.2021.05.008
[89] Predicting anti-cancer drug combination responses with a temporal cell state network model - PubMed. Accessed March 29, 2024. https://pubmed.ncbi.nlm.nih.gov/37126527/
[90] Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study - PubMed. Accessed March 29, 2024. https://pubmed.ncbi.nlm.nih.gov/31011206/
[91] Impact of organ-on-a-chip technology on pharmaceutical R&D costs - PubMed. Accessed March 29, 2024. https:// pubmed.ncbi.nlm.nih.gov/31185290/
[92] Ewart L, Apostolou A, Briggs SA, et al. Qualifying a human Liver-Chip for predictive toxicology: Performance assessment and economic implications. Published online August 2, 2022:2021.12.14.472674. doi:10.1101/2021.12.14.472674
[93] Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate) - PubMed. Accessed March 29, 2024. https://pubmed.ncbi.nlm.nih. gov/35064273/
[94] Baran SW, Brown PC, Baudy AR, et al. Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate). ALTEX - Altern Anim Exp. 2022;39(2):297-314. doi:10.14573/altex.2112203
Downloads
Published
Issue
Section
License
Copyright (c) 2024 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
